As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.
The news has been littered with stories these days about people losing weight using GLP-1 weight loss drugs like Ozempic. Now ...
As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.
Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...
The studies using animal research showed that GLP-1 drugs helped reduce cravings for several substances by affecting dopamine pathways. Some of the substances tested include alcohol, nicotine ...